NYSE American - Delayed Quote USD

Actinium Pharmaceuticals, Inc. (ATNM)

1.6400
-0.0600
(-3.53%)
At close: May 23 at 4:00:00 PM EDT
1.6400
0.00
(0.00%)
After hours: May 23 at 6:08:40 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
81
1,030
1,144
Operating Expense
49,162
42,121
52,001
35,134
26,108
Operating Income
-49,162
-42,121
-51,920
-34,104
-24,964
Net Non Operating Interest Income Expense
3,651
3,878
3,102
1,087
190
Pretax Income
-45,511
-38,243
-48,818
-33,017
-24,774
Net Income Common Stockholders
-45,511
-38,243
-48,818
-33,017
-24,774
Diluted NI Available to Com Stockholders
-45,511
-38,243
-48,818
-33,017
-24,774
Basic EPS
-1.47
-1.27
-1.83
-1.37
-1.20
Diluted EPS
-1.47
-1.27
-1.83
-1.37
-1.20
Basic Average Shares
30,897.3790
30,070.0280
26,604.0450
24,141.5450
20,568.3730
Diluted Average Shares
30,897.3790
30,070.0280
26,604.0450
24,141.5450
20,568.3730
Total Operating Income as Reported
-49,162
-42,121
-51,920
-34,104
-24,964
Total Expenses
49,162
42,121
52,001
35,134
26,108
Net Income from Continuing & Discontinued Operation
-45,511
-38,243
-48,818
-33,017
-24,774
Normalized Income
-45,511
-38,243
-48,818
-33,017
-24,774
Interest Income
3,651
3,878
3,102
1,087
190
Net Interest Income
3,651
3,878
3,102
1,087
190
EBIT
-49,162
-42,121
-51,920
-34,104
-24,964
EBITDA
-48,362
-41,310
-51,130
-33,405
-24,440
Reconciled Depreciation
800
811
790
699
524
Net Income from Continuing Operation Net Minority Interest
-45,511
-38,243
-48,818
-33,017
-24,774
Normalized EBITDA
-48,362
-41,310
-51,130
-33,405
-24,440
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 12/27/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CTXR Citius Pharmaceuticals, Inc.
0.7030
-2.90%
 
KPTI Karyopharm Therapeutics Inc.
4.5900
-1.08%
 
ABEO Abeona Therapeutics Inc.
6.42
-2.43%
 
ACET Adicet Bio, Inc.
0.6936
-3.49%
 
PDSB PDS Biotechnology Corporation
1.5800
+0.64%
 
ZURA Zura Bio Limited
1.0200
-1.92%
 
XFOR X4 Pharmaceuticals, Inc.
3.1000
-4.02%
 
AXSM Axsome Therapeutics, Inc.
105.07
+0.69%
 
VSTM Verastem, Inc.
8.31
+11.10%
 
SNDX Syndax Pharmaceuticals, Inc.
9.85
-8.88%